<!doctype html>
<html class="no-js" lang="en">

<head>
  <!-- Global site tag (gtag.js) - Google Analytics -->
  <script async src="https://www.googletagmanager.com/gtag/js?id=UA-134228602-13"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);}
    gtag('js', new Date());

    gtag('config', 'UA-134228602-13');
  </script>

  <meta charset="utf-8">
  <meta http-equiv="x-ua-compatible" content="ie=edge">
  <title>💾 🕖 🧑🏼 Bill Gates: What You Need to Know About COVID-19 Vaccine 🐫 🙇🏽 ⁉️</title>
  <link rel="icon" type="image/x-icon" href="/favicon.ico" />
  <meta name="description" content="Bill Gates, an engineer, businessman, and philanthropist, was attacked by supporters of absurd conspiracy theories claiming to be involved in the crea...">
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">

  <link rel="stylesheet" href="../../css/main.css">

  <link href="https://fonts.googleapis.com/css?family=Quicksand&display=swap" rel="stylesheet">

  <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.3.1/jquery.min.js"></script>
  <script>window.jQuery || document.write('<script src="../../js/vendors/jquery-3.3.1.min.js"><\/script>')</script>

  <script>document.write('<script src="//pagea' + 'd2.googles' + 'yndication.com/pagea' + 'd/js/a' + 'dsby' + 'google.js"><\/script>')</script>
  <script>
        var superSpecialObject = {};
        superSpecialObject['google_a' + 'd_client'] = 'ca-p' + 'ub-6974184241884155';
        superSpecialObject['enable_page_level_a' + 'ds'] = true;
       (window['a' + 'dsbygoogle'] = window['a' + 'dsbygoogle'] || []).push(superSpecialObject);
  </script>
</head>

<body>
  <!--[if lte IE 9]>
    <p class="browserupgrade">You are using an <strong>outdated</strong> browser. Please <a href="https://browsehappy.com/">upgrade your browser</a> to improve your experience and security.</p>
  <![endif]-->
  <header class="page-header js-page-header">
    <a class="page-header-logo-container" href="https://geek-week.github.io/index.html"></a>
    <div class="page-header-text">Get best of the week</div>
  </header>
  <section class="page js-page"><h1>Bill Gates: What You Need to Know About COVID-19 Vaccine</h1><div class="post__body post__body_full">
      <div class="post__text post__text-html post__text_v1" id="post-content-body" data-io-article-url="https://habr.com/ru/post/503588/"><i><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Bill Gates, an engineer, businessman, and philanthropist, </font></font><a href="https://translate.googleusercontent.com/translate_c?depth=1&amp;pto=aue&amp;rurl=translate.google.com&amp;sl=ru&amp;sp=nmt4&amp;tl=en&amp;u=" rel="nofollow"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">was attacked by supporters of absurd conspiracy theories</font></font></a><font style="vertical-align: inherit;"><font style="vertical-align: inherit;"> claiming to be involved in the creation of the coronavirus. In his blog, the creator of the world's largest private charitable foundation publishes analytical reviews, shares finds, recommends books and speeches. We are publishing a translation of an </font></font><a href="https://translate.googleusercontent.com/translate_c?depth=1&amp;pto=aue&amp;rurl=translate.google.com&amp;sl=ru&amp;sp=nmt4&amp;tl=en&amp;u=" rel="nofollow"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">article about the race to create a vaccine</font></font></a><font style="vertical-align: inherit;"><font style="vertical-align: inherit;"> against Covid-19 for the channel “ </font></font><a href="https://translate.googleusercontent.com/translate_c?depth=1&amp;pto=aue&amp;rurl=translate.google.com&amp;sl=ru&amp;sp=nmt4&amp;tl=en&amp;u=" rel="nofollow"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Rationally on Coronavirus</font></font></a><font style="vertical-align: inherit;"><font style="vertical-align: inherit;"> ”. </font></font><br>
</i><br>
<b><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Humanity has never faced a more urgent task than creating a general immunity to coronavirus.</font></font></b><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
One of the questions that I have been asked most often lately is when will the world be able to return to normal life as it was before the coronavirus pandemic, for example, in December. Each time I answer the same thing: when we have an almost perfect medicine for the treatment of COVID-19 or when almost all people on the planet will be vaccinated against coronavirus. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
The first is unlikely to happen anytime soon. To do this, we need a miracle cure effective in at least 95% of cases. Most drugs are now </font></font><a href="https://translate.googleusercontent.com/translate_c?depth=1&amp;pto=aue&amp;rurl=translate.google.com&amp;sl=ru&amp;sp=nmt4&amp;tl=en&amp;u=" rel="nofollow"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">far from such indicators</font></font></a><font style="vertical-align: inherit;"><font style="vertical-align: inherit;"> . They can save quite a few lives, but they are not enough so that we can return to a normal life. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
The search for a vaccine remains.</font></font><br>
<a name="habracut"></a><br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
Humanity has never faced a more urgent task than creating a general immunity to coronavirus. </font><font style="vertical-align: inherit;">Indeed, if we want to return to normal, we need to develop a safe and effective vaccine. </font><font style="vertical-align: inherit;">We will need to produce billions of doses of the vaccine, deliver them anywhere in the world, and do it as quickly as possible. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
And that really sounds scary. </font><font style="vertical-align: inherit;">Our foundation is the largest vaccine sponsor in the world, and trying to cope with the current situation overshadows everything we have ever worked on. </font><font style="vertical-align: inherit;">A solution will require a global collaborative effort, still unknown. </font><font style="vertical-align: inherit;">But I know that we can handle it. </font><font style="vertical-align: inherit;">We just have no choice. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
That's all you need to know about the COVID-19 vaccine race.</font></font><br>
<br>
<h3><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">The world is working on a vaccine in the shortest time in history</font></font><br>
</h3><br>
<a href="https://translate.googleusercontent.com/translate_c?depth=1&amp;pto=aue&amp;rurl=translate.google.com&amp;sl=ru&amp;sp=nmt4&amp;tl=en&amp;u=" rel="nofollow"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Dr. Anthony Fauci said</font></font></a><font style="vertical-align: inherit;"><font style="vertical-align: inherit;"> that, in his opinion, the development of a coronavirus vaccine will take about eighteen months. I agree with him, the spread can be from 9 months to two years. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
And although eighteen months may seem like a long time, this will be the minimum time for scientists to create a new vaccine. Development usually takes about five years: you need to create the vaccine itself and test it on animals, and then conduct testing for safety and effectiveness in humans. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
Safety and efficacy are the two main characteristics of the new vaccine. </font></font><b><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Safety</font></font></b><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- How safe is this vaccine for people? Minor side effects (such as a slight fever or pain at the injection site) may be acceptable, but you are unlikely to want to give the vaccines to people with something that will make them sick. </font></font><br>
<br>
<b><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Efficiency</font></font></b><font style="vertical-align: inherit;"><font style="vertical-align: inherit;"> shows how well the vaccine protects against disease. And although I would like to receive a vaccine with 100 percent effectiveness, in reality, many are worse in this parameter. For example, </font></font><a href="https://translate.googleusercontent.com/translate_c?depth=1&amp;pto=aue&amp;rurl=translate.google.com&amp;sl=ru&amp;sp=nmt4&amp;tl=en&amp;u=" rel="nofollow"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">the flu vaccine is about 45 percent effective this year</font></font></a><font style="vertical-align: inherit;"><font style="vertical-align: inherit;"> . </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
To test safety and efficacy, each vaccine undergoes three phases of testing:</font></font><br>
<br>
<ul>
<li><b> </b> —   .        .                    .</li>
<li>  ,    <b> </b>,  ,      ,   .               .</li>
<li> <b> </b>   .    ,        «  » —    ,     .    ,     .</li>
</ul><br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
After the vaccine has successfully completed all three phases of the test, you can begin the production cycle and apply for registration with WHO and other government agencies: </font></font><br>
<br>
<img src="https://habrastorage.org/webt/tt/5j/yt/tt5jyt0fw-go8xjrtgzk8ntt518.jpeg" alt="image"><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
This process works well at normal times, but in the current situation, the standard development times are too long. If we can speed up getting vaccines even for a day, it will have a huge impact on the world both to save lives and reduce the economic damage in the trillions of dollars. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
Therefore, vaccine developers are trying to shorten the time: </font></font><br>
<br>
<img src="https://habrastorage.org/webt/ps/yz/fa/psyzfajs_j7iupzfmqzlje61s4c.jpeg" alt="image"><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
In the standard process, key issues are resolved sequentially to reduce financial risks, vaccine development is very expensive. Many candidate vaccines fail, so companies first expect success at one stage before investing in the next.</font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
For COVID-19, funding is not a major concern. </font><font style="vertical-align: inherit;">Governments and other organizations, including our foundation and a terrific alliance called the </font></font><a href="https://translate.googleusercontent.com/translate_c?depth=1&amp;pto=aue&amp;rurl=translate.google.com&amp;sl=ru&amp;sp=nmt4&amp;tl=en&amp;u=" rel="nofollow"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Epidemic Preparedness Innovation Coalition</font></font></a><font style="vertical-align: inherit;"><font style="vertical-align: inherit;"> , said they were ready to do anything to get the vaccine. </font><font style="vertical-align: inherit;">This way, scientists can save time by completing several stages of development at the same time. </font><font style="vertical-align: inherit;">For example, private companies, governments, and our foundation are about to start looking for businesses to produce various potential vaccines. </font><font style="vertical-align: inherit;">Some enterprises will not be involved in the end, but this is a small price for accelerating production.</font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
Fortunately, shortening the testing time is not the only way to speed up the process, which usually takes five years, to 18 months. </font><font style="vertical-align: inherit;">Another way that we have resorted to is the simultaneous testing of many approaches.</font></font><br>
<br>
<h3><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Dozens of candidate vaccines in development</font></font></h3><br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
As of April 9, </font></font><a href="https://translate.googleusercontent.com/translate_c?depth=1&amp;pto=aue&amp;rurl=translate.google.com&amp;sl=ru&amp;sp=nmt4&amp;tl=en&amp;u=" rel="nofollow"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">115 candidate vaccines against COVID-19</font></font></a><font style="vertical-align: inherit;"><font style="vertical-align: inherit;"> were already in development </font><font style="vertical-align: inherit;">. </font><font style="vertical-align: inherit;">I believe that 8-10 of them look especially promising, but our fund will follow everyone so as not to miss others with good characteristics:</font></font><br>
<br>
<iframe width="560" height="315" src="https://www.youtube.com/embed/u1AQ5EXcJYc" frameborder="0" allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen=""></iframe><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
The most promising candidates use different approaches to protect the body from COVID-19. To understand them, it is useful to recall how the human immune system works. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
When a pathogen enters the body, the immune system responds by producing antibodies. They attach to substances called </font></font><b><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">antigens</font></font></b><font style="vertical-align: inherit;"><font style="vertical-align: inherit;"> on the surface of the pathogen and serve as an attack signal to the body. The immune system keeps track of all those who have ever been defeated in order to quickly recognize and destroy the invaders in the future, before they cause the disease.</font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
Vaccines bypass this whole process, teaching the body how to deal with pathogens without disease. The two most common types — the ones you are probably most familiar with — are inactivated and live vaccines. Inactivated vaccines contain killed pathogens, while in live ones they are attenuated (attenuated). Live vaccines are very effective, but often give side effects. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
Inactivated and live vaccines are “traditional” approaches. There are a number of candidate vaccines from COVID-19 of both types, and not by chance: they are well known - we understand how to test and produce them. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
But their production is time consuming. For each dose of vaccine, a large number of materials, mainly biological, that is, requiring long-term cultivation, are required.</font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
Therefore, I am inspired by two new approaches that are used in some candidates: </font></font><b><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">RNA</font></font></b><font style="vertical-align: inherit;"><font style="vertical-align: inherit;"> and </font></font><b><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">DNA vaccines</font></font></b><font style="vertical-align: inherit;"><font style="vertical-align: inherit;"> . If one of these new approaches works, we are likely to be able to distribute vaccines around the world much faster. (For the sake of simplicity, I will only talk about RNA vaccines. DNA vaccines differ in the type of genetic material and the method of administration, but are generally similar). </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
Our fund - both through our own financing, and </font></font><a href="https://translate.googleusercontent.com/translate_c?depth=1&amp;pto=aue&amp;rurl=translate.google.com&amp;sl=ru&amp;sp=nmt4&amp;tl=en&amp;u=" rel="nofollow"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">through CEPI</font></font></a><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">- supported the development of RNA vaccines for the last ten years. We planned to create vaccines for diseases that affect poor countries, such as malaria, and now it looks like one of the most promising options for COVID-19. The first candidate to start human trials was the Moderna RNA vaccine. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
Here's how the RNA vaccine works: instead of injecting the pathogen antigen into the body, they give him the genetic code necessary for self-production of the antigen. When antigens appear outside the cells, the immune system attacks them - and learns how to defeat future intruders. In essence, you are turning your body into your own vaccine division.</font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
Since RNA vaccines allow your body to do most of the work, they don’t need a lot of biomaterial, which makes them much faster in production. </font><font style="vertical-align: inherit;">But it is not yet known for sure whether RNA is a viable basis for vaccines - it is necessary to prove that the vaccine works and creates immunity. </font><font style="vertical-align: inherit;">This is a bit like the simultaneous development of the computer itself and the programs for it. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
So even if the RNA vaccine looks promising, you can not stop there. </font><font style="vertical-align: inherit;">It is not yet known which vaccine against COVID-19 will be successful, so we must put all our energy into studying the maximum number of approaches to creating a vaccine.</font></font><br>
<br>
<h3><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">The vaccine probably won't be perfect - and that's fine</font></font></h3><br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
Smallpox vaccine is the only disease that has wiped out the face of the earth. Its use is rather traumatic: it leaves a scar on the vaccinated hand. One in three was forced to miss school or work due to side effects. A small but significant number of people have more serious reactions. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
The smallpox vaccine was far from perfect, but it did its job. The vaccine COVID-19 may be similar. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
An ideal sample would be 100% safe and 100% effective. A single dose would be enough to provide protection for life. It could easily be stored and delivered. I would like the COVID-19 vaccine to have all of these qualities, but given the timing, things will probably be different. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
The key priorities, as I mentioned earlier, are </font></font><b><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">security.</font></font></b><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">and </font><font style="vertical-align: inherit;">vaccine </font></font><b><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">efficacy</font></font></b><font style="vertical-align: inherit;"><font style="vertical-align: inherit;"> . Since there is no time for many years of research, it will be necessary to conduct extensive tests in the first phase and make sure that we have enough data on its complete safety. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
As for the effectiveness of the vaccine, there is more room for maneuver. It seems to me that 70 percent efficiency will be enough to stop the pandemic. You can even use a vaccine that is 60 percent effective, although in this case local outbreaks can occur. Efficiency below 60 percent is unlikely to create sufficient population immunity to stop the virus.</font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
It will be very difficult to ensure good vaccine performance in the elderly. The older the person, the less effective the vaccine for him. The immune system, like the rest of the body, is aging and slower recognizing and attacking intruders. This is a big problem for the COVID-19 vaccine, as older people are the most vulnerable. We need to make sure that they are protected. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
In the case of the shingles vaccine - it is also intended for older people - the solution was to increase the strength of the vaccine. We may do something similar for COVID-19, but this can lead to more side effects. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
In addition to the safety and efficacy of vaccines, several other factors must be considered:</font></font><br>
<br>
<ul>
<li><b>  ?</b> ,   ,    . , ,        . </li>
<li><b>   ? </b>     ,     ,       (,       ).       ,      . </li>
<li><b>  ? </b>    4 °C —      ,      .  -       ,    -80 °C,       . </li>
</ul><br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
I want to believe that the vaccine, which will be ready in 18 months, will be as close to “ideal” as possible. </font><font style="vertical-align: inherit;">Even if this does not happen, we will continue to work to improve it. </font><font style="vertical-align: inherit;">I suspect that the COVID-19 vaccine will be part of routine immunization of newborns. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
However, after the vaccine appears, we still have to solve huge problems. </font><font style="vertical-align: inherit;">Because…</font></font><br>
<br>
<h3><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">At least 7 billion doses of vaccine needed to be manufactured and distributed.</font></font><br>
</h3><br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
To stop the pandemic, we need to provide a vaccine for almost all people on the planet. We had never before solved the task of delivering something to all corners of the world. And, as I said earlier, vaccines are especially difficult to produce and store. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
Moreover, until we have decided on the type of vaccine, it is difficult to say how we will manufacture and distribute the vaccine. For example, can we use existing factories to produce COVID-19 vaccine?</font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
But we can prepare various types of production in advance. For each type of vaccine, different types of factories are needed, so different preparations will have to be made in order to start making the selected vaccine as soon as possible. It will cost billions of dollars, so governments need to quickly find a funding mechanism. Our foundation is currently working with CEPI, WHO and governments to solve this problem. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
Part of the discussion is about who will get the vaccine and when. The reality is that not everyone can get the vaccine at the same time. It will take months — or even years — to create 7 billion doses (or, for example, 14 billion if it is a multi-dose vaccine), and we must begin to distribute them as soon as the first batch is ready.</font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
Most people agree that healthcare providers should take precedence, but who will receive it later? Aged people? Teachers? Workers in key occupations? </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
I think that low-income countries should be among the first recipients of the vaccine, because people in these places are at greater risk. COVID-19 will spread much faster in poor countries because it is more difficult to maintain physical distance. Many have health problems, making complications more likely, and weak health systems make it difficult to get the help they need. Spreading the vaccine in low-income countries can save millions of lives. Fortunately, we already have an organization with the necessary experience - </font></font><a href="https://translate.googleusercontent.com/translate_c?depth=1&amp;pto=aue&amp;rurl=translate.google.com&amp;sl=ru&amp;sp=nmt4&amp;tl=en&amp;u=" rel="nofollow"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Gavi, the Vaccination Alliance</font></font></a><font style="vertical-align: inherit;"><font style="vertical-align: inherit;"> .</font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
As a rule, the vaccine manufacturer signs agreements with the countries in which their production is located on the priority receipt of vaccines. It is unclear whether this will be the case with COVID-19. I hope we find a way to distribute the vaccine equally throughout the world. WHO and national health organizations will need to develop a distribution plan as soon as we understand exactly what we will work with. </font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
Ultimately, the process will reach a scale enough to provide everyone with the vaccine. And then we can return to normal life and, I hope, take measures so as not to be in a similar situation again.</font></font><br>
<br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
There is light at the end of the tunnel, even if it is not yet visible. </font><font style="vertical-align: inherit;">We are taking the right steps to get the vaccine as soon as possible. </font><font style="vertical-align: inherit;">In the meantime, I urge you to continue to follow the recommendations of your local authorities. </font><font style="vertical-align: inherit;">Our chances of dealing with a pandemic are directly dependent on each other's security concerns. </font></font><br>
<br>
<i><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Translation: </font></font><a href="https://translate.googleusercontent.com/translate_c?depth=1&amp;pto=aue&amp;rurl=translate.google.com&amp;sl=ru&amp;sp=nmt4&amp;tl=en&amp;u=" rel="nofollow"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Anton Bely</font></font></a><font style="vertical-align: inherit;"><font style="vertical-align: inherit;"> for the telegram channel “ </font></font><a href="https://translate.googleusercontent.com/translate_c?depth=1&amp;pto=aue&amp;rurl=translate.google.com&amp;sl=ru&amp;sp=nmt4&amp;tl=en&amp;u=" rel="nofollow"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Rationally about Coronavirus</font></font></a><font style="vertical-align: inherit;"><font style="vertical-align: inherit;"> ” </font></font><br><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">
Edited by </font></font><a href="https://translate.googleusercontent.com/translate_c?depth=1&amp;pto=aue&amp;rurl=translate.google.com&amp;sl=ru&amp;sp=nmt4&amp;tl=en&amp;u=" rel="nofollow"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Tatyana Lando</font></font></a><font style="vertical-align: inherit;"><font style="vertical-align: inherit;"> and </font></font><a href="https://translate.googleusercontent.com/translate_c?depth=1&amp;pto=aue&amp;rurl=translate.google.com&amp;sl=ru&amp;sp=nmt4&amp;tl=en&amp;u=" rel="nofollow"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">Dmitry Kalupin</font></font></a></i></div>
      
    </div>
<section class="more-articles-navigation-panel js-more-articles-navigation-panel">
<h4>More articles:</h4>
<nav class="list-of-articles-container js-list-of-articles-container"><ul class="list-of-pages js-list-of-pages">
<li><a href="../en503572/index.html">Udalenka. another self-isolation VPN deployment story</a></li>
<li><a href="../en503574/index.html">Analysis of the contents of QR codes in documents of the electronic government of the Republic of Kazakhstan in the frontend</a></li>
<li><a href="../en503576/index.html">"Passed by": topics that you forgot to discuss on Russian-speaking sites about startups and technologies</a></li>
<li><a href="../en503578/index.html">Good programmers copy, great programmers steal</a></li>
<li><a href="../en503580/index.html">What is Big Data?</a></li>
<li><a href="../en503594/index.html">Remote observer</a></li>
<li><a href="../en503598/index.html">FOSS News No. 17 - review of free and open source news for May 18-24, 2020</a></li>
<li><a href="../en503600/index.html">STM32MP1: U-Boot, Buildroot, Arch Linux and a little Debian</a></li>
<li><a href="../en503604/index.html">Sergey and “programming is better than sex”</a></li>
<li><a href="../en503606/index.html">Swift 5.3: What's New?</a></li>
</ul></nav>
</section><br />
<a href="../../allArticles.html"><strong>All Articles</strong></a>
<script src="../../js/main.js"></script>

<!-- Yandex.Metrika counter -->
<script type="text/javascript" >
  (function (d, w, c) {
      (w[c] = w[c] || []).push(function() {
          try {
              w.yaCounter63335242 = new Ya.Metrika({
                  id:63335242,
                  clickmap:true,
                  trackLinks:true,
                  accurateTrackBounce:true,
                  webvisor:true
              });
          } catch(e) { }
      });

      var n = d.getElementsByTagName("script")[0],
          s = d.createElement("script"),
          f = function () { n.parentNode.insertBefore(s, n); };
      s.type = "text/javascript";
      s.async = true;
      s.src = "https://mc.yandex.ru/metrika/watch.js";

      if (w.opera == "[object Opera]") {
          d.addEventListener("DOMContentLoaded", f, false);
      } else { f(); }
  })(document, window, "yandex_metrika_callbacks");
</script>
<noscript><div><img src="https://mc.yandex.ru/watch/63335242" style="position:absolute; left:-9999px;" alt="" /></div></noscript>

<!-- Google Analytics -->
  <script>
    window.ga = function () { ga.q.push(arguments) }; ga.q = []; ga.l = +new Date;
    ga('create', 'UA-134228602-13', 'auto'); ga('send', 'pageview')
  </script>
  <script src="https://www.google-analytics.com/analytics.js" async defer></script>

</section>

<footer class="page-footer">
  <div class="page-footer-legal-info-container page-footer-element">
    <p>
      Geek Week | <span class="page-footer-legal-info-year js-page-footer-legal-info-year">2020</span>
    </p>
  </div>
  <div class="page-footer-counters-container page-footer-element">
    <a class="page-footer-counter-clustrmap" href='#'  title='Visit tracker'><img src='https://clustrmaps.com/map_v2.png?cl=698e5a&w=271&t=t&d=i62cJ2037o_BACd40gCrIso3niu0Sjx2sDFYJkeYdRk&co=3a3a3a&ct=ffffff'/></a>
  </div>
</footer>
  
</body>

</html>